Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 5, 2007, Pages 662-671

  Chinushi, Masaomi ^a   Komura, Satoru ^a   Izumi, Daisuke ^a   Furushima, Hiroshi ^a   Tanabe, Yasutaka ^a   Washizuka, Takashi ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Brugada syndrome; Triggered extrasystole; Ventricular tachyarrhythmia

Indexed keywords

ISOPRENALINE; PILSICAINIDE;

ADULT; AGED; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIAGNOSTIC TEST; ECG ABNORMALITY; ELECTROCARDIOGRAM; ELECTROSTIMULATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; MALE; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; SIDE EFFECT; ST SEGMENT ELEVATION;

ADULT; AGED; ARRHYTHMIA; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; INCIDENCE; LIDOCAINE; MALE; MIDDLE AGED; SODIUM CHANNEL BLOCKERS;

EID: 34247471670     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00728.x     Document Type: Article

References (32)

1. Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, Brugada P. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000 101 : 510 515.
2. Wilde A, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, et al. for the Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology. Proposed Diagnostic Criteria for the Brugada Syndrome. Circulation 2002 106 : 2514 2519.
3. Wolpert C, Echternach C, Veltmann C, Antzelvitch C, Thomas GP, Spehl S, Streitner F, et al. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm 2005 2 : 254 260.
4. Chinushi Y, Chinushi M, Toida T, Aizawa Y. A class I antiarrhythmic drug and coronary vasospasm induced T-wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina. J Cardiovasc Electrophysiol 2002 13 : 191 194.
5. Takagi M, Doi A, Takeuchi K, Yoshikawa J. Pilsicainide-induced marked T wave alternans and ventricular fibrillation in a patient Brugada syndrome. J Cardiovasc Electrophysiol 2002 13 : 837.
6. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999 100 : 1660 1666.
7. Kurita T, Shimizu W, Inagaki M, Suyama K, Taguchi A, Satomi K, Aihara N, et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 2002 40 : 330 334.
8. Aiba T, Shimizu W, Hidaka I, Uemura K, Noda T, Zheng C, Kamiya A, et al. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model. J Am Coll Cardiol 2006 47 : 2074 2085
9. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, Bloise R, et al. Natural history of Brugada syndrome: Insights for the risk stratification and management. Circulation 2002 105 : 1342 1347.
10. Hong K, Brugada J, Oliva A, Berruezo Sanchez A, Potenza D, Pollevick GD, Guerchicoff A, et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004 110 : 3023 3027.
11. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, et al. Brugada syndrome, Report of the second consensus conference. Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005 111 : 659 670.
12. Antzelevitch C. Brugada syndrome. Review. Pacing Clin Electrophysiol 2006 29 : 1130 1159.
13. Di Diego J, Fish J, Antzelevitch C. Brugada syndrome and ischemia-induced ST-segment elevation. Similarities and differences. J Electrocardiol 2005 38 : 14 17.
14. Shimizu W, Aiba T, Kurita T, Kamakura S. Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation. J Cardiovasc Electrophysiol 2001 12 : 1418 1421.
15. Meregalli PG, Wilde AA, Tan HL. Path physiological mechanisms of Brugada syndrome: Dispersion disorder, repolarization disorder, or more? Cardiovasc Res 2005 67 : 367 378.
16. Tukkie R, Sogaard P, Vleugels J, de Groot KLM, Wilde AAM, Tan HL. Dealy in the right ventricular activation contributes to Brugada syndrome. Circulation 2004 109 : 1272 1277.
17. Eckardt L, Bruns HJ, Paul M, Kirchhof P, Schulze-Bahr E, Wichter T, Breithardt G, et al. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome. J Cardiovasc Electrophysiol 2002 13 : 742 749.
18. Furushima H, Chinushi M, Hirono T, Sugiura H, Watanabe H, Komura S, Washizuka T, et al. Relationship between dominant prolongation of the filtered QRS duration in the right precordial leads and clinical characteristics in Brugada syndrome. J Cardiovasc Electrophysiol 2005 16 : 1311 1317.
19. Nagase S, Kusano KF, Morita H, Fujimoto Y, Kakishita M, Nakamura K, Emori T, et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome. J Am Coll Cardiol 2002 39 : 1992 1995.
20. Morita H, Morita TS, Nagase S, Banba K, Nishii N, Tani Y, Watanabe A, et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 2003 42 : 1624 1631.
21. Kanda M, Shimizu W, Matsuo K, Nagaya N, Taguchi A, Suyama K, Kurita T, et al. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol 2002 39 : 1799 1805.
22. Yokokawa M, Takaki H, Noda T, Satomi K, Suyama K, Kurita T, Kamakura S, et al. Spatial distribution of repolarization and depolarization abnormalities evaluated by body surface potential mapping in patients with Brugada syndrome. Pacing Clin Electrophysiol 2006 29 : 1112 1121.
23. Ogawa M, Kumagai K, Yamanouchi Y, Saku K. Spontaneous onset of ventricular fibrillation in Brugada syndrome with J wave and ST-segment elevation in the inferior leads. Heart Rhythm 2005 2 : 97 99.
24. Maury P, Couderc P, Delay M, Boveda S, Brugada J. Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace 2004 6 : 130 133.
25. Watanabe H, Chinushi M, Washizuka T, Sugiura H, Hirono T, Komura S, Hosaka Y, et al. Variable electrocardiographic effects of short-term quinidine sulfate administration in Brugada syndrome. Pacing Clin Electrophysiol 2005 28 : 372 377.
26. Haissaguerre M, Extramiana F, Hocini M, Cauchemez B, Jais P, Cabrera JA, Farre G, et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndrome. Circulation 2003 108 : 925 928.
27. Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Geriotti C, Simonini S. Flecainide test in Brugada syndrome: A reproducible but risky tool. Pacing Clin Electrophysiol 2003 26 : 338 341.
28. Meregalli PG, Ruijter JM, Hofman N, Bezzina CR, Wilde AAM, Tan HL. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 2006 17 : 857 864.
29. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrophysiologic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002 5 : 73 78.
30. Takenaka S, Kusano KF, Hisamatsu K, Nagase S, Nakamura K, Morita H, Matsubara H, et al. Relatively benign clinical course in asymptomatic patients with Brugada type electrogram without family history of sudden cardiac death. J Cardiovasc Electrophysiol 2001 12 : 2 6.
31. Atarashi H, Ogawa S, Harumi K, Sugimoto T, Inoue H, Maruyama M, Toyama J, et al, Idiopathic ventricular fibrillation investigators. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese Registry of Brugada Syndrome. Idiopathic Ventricular Fibrillation Investigators. J Am Coll Cardiol 2001 37 : 1916 1920.
32. Eckardt L, Probst V, Smits JPP, Bahr ES, Wolpert C, Schimpf R, Wichter T, et al. Long-term prognosis of individuals with right precordial ST-segment elevation Brugada syndrome. Circulation 2005 111 : 257 263.